Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Didiot MC"'
Autor:
Ly S; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Ferguson CM; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Coles AH; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Miller R; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Chase K; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Wang F; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Sadri-Vakili G; Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, MA 02114, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Publikováno v:
Brain communications [Brain Commun] 2022 Oct 13; Vol. 4 (6), pp. fcac248. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Autor:
Haraszti RA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: rharaszti@gmail.com., Miller R; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Dubuke ML; Mass Spectrometry Facility, Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Shrewsbury, MA, USA., Rockwell HE; BERG LLC, Framingham, MA, USA., Coles AH; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Sapp E; Mass General Institute for Neurodegenerative Disease, Boston, MA, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Stoppato M; MassBiologics, Boston, MA, USA., Sere YY; MassBiologics, Boston, MA, USA., Leszyk J; Mass Spectrometry Facility, Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Shrewsbury, MA, USA., Alterman JF; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Godinho BMDC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Hassler MR; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., McDaniel J; BERG LLC, Framingham, MA, USA., Narain NR; BERG LLC, Framingham, MA, USA., Wollacott R; MassBiologics, Boston, MA, USA., Wang Y; MassBiologics, Boston, MA, USA., Shaffer SA; Mass Spectrometry Facility, Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Shrewsbury, MA, USA., Kiebish MA; BERG LLC, Framingham, MA, USA., DiFiglia M; Mass General Institute for Neurodegenerative Disease, Boston, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: neil.aronin@umassmed.edu., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: anastasia.khvorova@umassmed.edu.
Publikováno v:
IScience [iScience] 2019 Jun 28; Vol. 16, pp. 230-241. Date of Electronic Publication: 2019 May 27.
Autor:
Haraszti RA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Miller R; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Stoppato M; MassBiologics, Boston, MA, USA., Sere YY; MassBiologics, Boston, MA, USA., Coles A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Wollacott R; MassBiologics, Boston, MA, USA., Sapp E; Mass General Institute for Neurodegenerative Disease, Boston, MA, USA., Dubuke ML; Mass Spectrometry Facility, University of Massachusetts Medical School, Shrewsbury, MA, USA., Li X; Mass Spectrometry Facility, University of Massachusetts Medical School, Shrewsbury, MA, USA., Shaffer SA; Mass Spectrometry Facility, University of Massachusetts Medical School, Shrewsbury, MA, USA., DiFiglia M; Mass General Institute for Neurodegenerative Disease, Boston, MA, USA., Wang Y; MassBiologics, Boston, MA, USA., Aronin N; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: neil.aronin@umassmed.edu., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: anastasia.khvorova@umassmed.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2018 Dec 05; Vol. 26 (12), pp. 2838-2847. Date of Electronic Publication: 2018 Sep 22.
Autor:
Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: marie.didiot@umassmed.edu., Ferguson CM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Ly S; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Coles AH; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Smith AO; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Bicknell AA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Hall LM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Sapp E; MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA 02129, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Pai AA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., DiFiglia M; MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA 02129, USA., Moore MJ; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA., Hayward LJ; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: anastasia.khvorova@umassmed.edu.
Publikováno v:
Cell reports [Cell Rep] 2018 Sep 04; Vol. 24 (10), pp. 2553-2560.e5.
Autor:
Haraszti RA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Miller R; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Biscans A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Alterman JF; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Hassler MR; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Roux L; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Sapp E; Mass General Institute for Neurodegenerative Disease, Boston, MA, USA., DiFiglia M; Mass General Institute for Neurodegenerative Disease, Boston, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: neil.aronin@umassmed.edu., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: anastasia.khvorova@umassmed.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2018 Aug 01; Vol. 26 (8), pp. 1973-1982. Date of Electronic Publication: 2018 Jun 21.
Autor:
Biscans A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Haraszti RA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Miller R; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Nikan M; Ionis Pharmaceutical, Carlsbad, CA 92010, USA., Roux L; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: neil.aronin@umassmed.edu., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: anastasia.khvorova@umassmed.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2018 Jun 06; Vol. 26 (6), pp. 1520-1528. Date of Electronic Publication: 2018 Apr 04.
Autor:
Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Haraszti RA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA. anastasia.khvorova@umassmed.edu.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. anastasia.khvorova@umassmed.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2018; Vol. 1740, pp. 199-214.
Autor:
Alterman JF; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Coles AH; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Hall LM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Publikováno v:
Bio-protocol [Bio Protoc] 2017 Aug 20; Vol. 7 (16).
Autor:
Haraszti RA; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Coles A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Aronin N; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA., Didiot MC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Publikováno v:
Bio-protocol [Bio Protoc] 2017 Jun 20; Vol. 7 (20).
Autor:
Ly S; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01655, USA., Navaroli DM; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA., Didiot MC; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01655, USA., Cardia J; RXi Pharmaceuticals, Marlborough, MA 01752, USA., Pandarinathan L; RXi Pharmaceuticals, Marlborough, MA 01752, USA., Alterman JF; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01655, USA., Fogarty K; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA., Standley C; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA., Lifshitz LM; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA., Bellve KD; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA., Prot M; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA., Echeverria D; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01655, USA., Corvera S; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA silvia.corvera@umassmed.edu., Khvorova A; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA anastasia.khvorova@umassmed.edu.; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2017 Jan 09; Vol. 45 (1), pp. 15-25. Date of Electronic Publication: 2016 Nov 28.